Cargando…

V374A KCND3 Pathogenic Variant Associated With Paroxysmal Ataxia Exacerbations

OBJECTIVE: Ataxia channelopathies share common features such as slow motor progression and variable degrees of cognitive dysfunction. Mutations in potassium voltage-gated channel subfamily D member 3 (KCND3), encoding the K+ channel, Kv4.3, are associated with spinocerebellar ataxia (SCA) 19, alleli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paucar, Martin, Ågren, Richard, Li, Tianyi, Lissmats, Simon, Bergendal, Åsa, Weinberg, Jan, Nilsson, Daniel, Savichetva, Irina, Sahlholm, Kristoffer, Nilsson, Johanna, Svenningsson, Per
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862093/ https://www.ncbi.nlm.nih.gov/pubmed/33575485 http://dx.doi.org/10.1212/NXG.0000000000000546

Ejemplares similares

An E280K Missense Variant in KCND3/Kv4.3—Case Report and Functional Characterization
por: Ågren, Richard, et al.
Publicado: (2023)

On Spinocerebellar Ataxia 21 as a Mimicker of Cerebral Palsy
por: van der Put, Johanna, et al.
Publicado: (2022)

Novel Features and Abnormal Pattern of Cerebral Glucose Metabolism in Spinocerebellar Ataxia 19
por: Paucar, Martin, et al.
Publicado: (2018)

A Second Case With the V374A KCND3 Pathogenic Variant in an Italian Patient With Early-Onset Spinocerebellar Ataxia
por: Palombo, Flavia, et al.
Publicado: (2022)

Paroxysmal Kinesigenic Dyskinesia
por: Paucar, Martin, et al.
Publicado: (2017)

The Beta-Arrestin-Biased Dopamine D(2) Receptor Ligand, UNC9994, Is a Partial Agonist at G-Protein-Mediated Potassium Channel Activation
por: Ågren, Richard, et al.
Publicado: (2018)

In Vitro Comparison of Ulotaront (SEP-363856) and Ralmitaront (RO6889450): Two TAAR1 Agonist Candidate Antipsychotics
por: Ågren, Richard, et al.
Publicado: (2023)

TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT(1A) receptor agonist SEP-363856
por: Saarinen, Marcus, et al.
Publicado: (2022)

Correction To: TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT(1A) receptor agonist SEP- 363856
por: Saarinen, Marcus, et al.
Publicado: (2022)

Broader phenotypic traits and widespread brain hypometabolism in spinocerebellar ataxia 27
por: Paucar, M., et al.
Publicado: (2020)

Voltage-Dependent Dopamine Potency at D(1)-Like Dopamine Receptors
por: Ågren, Richard, et al.
Publicado: (2020)

Evidence for Two Modes of Binding of the Negative Allosteric Modulator SB269,652 to the Dopamine D(2) Receptor
por: Ågren, Richard, et al.
Publicado: (2021)

Adult-Onset Ataxia With Neuropathy and White Matter Abnormalities Due to a Novel SAMD9L Variant
por: Paucar, Martin, et al.
Publicado: (2021)

Rare Gain-of-Function KCND3 Variant Associated with Cerebellar Ataxia, Parkinsonism, Cognitive Dysfunction, and Brain Iron Accumulation
por: Hsiao, Cheng-Tsung, et al.
Publicado: (2021)

Progressive Ataxia with Elevated Alpha-Fetoprotein: Diagnostic Issues and Review of the Literature
por: Paucar, Martin, et al.
Publicado: (2019)

Expanding the ataxia with oculomotor apraxia type 4 phenotype
por: Paucar, Martin, et al.
Publicado: (2016)

A Novel Duplication in ATXN2 as Modifier for Spinocerebellar Ataxia 3 (SCA3) and C9ORF72‐ALS
por: Laffita‐Mesa, Jose Miguel, et al.
Publicado: (2020)

Progressive brain calcifications and signs in a family with the L9R mutation in the PDGFB gene
por: Paucar, Martin, et al.
Publicado: (2016)

Association of Cardiac Electrical Disorders With KCND3 Gene Mutation
por: Ahammed, Md Ripon, et al.
Publicado: (2023)

Chorea, psychosis, acanthocytosis, and prolonged survival associated with ELAC2 mutations
por: Paucar, Martin, et al.
Publicado: (2018)

KCND3-Related Neurological Disorders: From Old to Emerging Clinical Phenotypes
por: Pollini, Luca, et al.
Publicado: (2020)

A Novel KCND3 Variant in a Korean Family With SCA19
por: Ha, Hongmin, et al.
Publicado: (2022)

Rare KCND3 Loss-of-Function Mutation Associated With the SCA19/22
por: Li, Mengjie, et al.
Publicado: (2022)

KCND2: A prognostic biomarker and regulator of immune function in gastric cancer
por: Zhou, Hongying, et al.
Publicado: (2023)

Dopamine D(2) Receptor Agonist Binding Kinetics—Role of a Conserved Serine Residue
por: Ågren, Richard, et al.
Publicado: (2021)

A novel KCND3 mutation associated with early-onset lone atrial fibrillation
por: Huang, Yuan, et al.
Publicado: (2017)

Cardiocerebral channelopathy caused by KCND3 mutation in a child: A case report
por: Zhang, Yi, et al.
Publicado: (2022)

Major Genetic Risk Factors for Dupuytren's Disease Are Inherited From Neandertals
por: Ågren, Richard, et al.
Publicado: (2023)

First de novo KCND3 mutation causes severe Kv4.3 channel dysfunction leading to early onset cerebellar ataxia, intellectual disability, oral apraxia and epilepsy
por: Smets, Katrien, et al.
Publicado: (2015)

KCND3 potassium channel gene variant confers susceptibility to electrocardiographic early repolarization pattern
por: Teumer, Alexander, et al.
Publicado: (2019)

GLRA1 mutation and long-term follow-up of the first hyperekplexia family
por: Paucar, Martin, et al.
Publicado: (2018)

Pathological Study of a FMR1 Premutation Carrier With Progressive Supranuclear Palsy
por: Paucar, Martin, et al.
Publicado: (2018)

Novel KCND3 Variant Underlying Nonprogressive Congenital Ataxia or SCA19/22 Disrupt K(V)4.3 Protein Expression and K+ Currents with Variable Effects on Channel Properties
por: Zanni, Ginevra, et al.
Publicado: (2021)

An unusual cause of fatal rapid-onset ataxia plus syndrome
por: Kmezic, Ivan, et al.
Publicado: (2017)

Early repolarization syndrome caused by de novo duplication of KCND3 detected by next-generation sequencing
por: Chauveau, Samuel, et al.
Publicado: (2017)

Long non-coding RNA KCND1 protects hearts from hypertrophy by targeting YBX1
por: Yang, Rui, et al.
Publicado: (2023)

Acetazolamide-responsive hereditary paroxysmal ataxia: report of a family.
por: Kim, H. J., et al.
Publicado: (1998)

Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias
por: Garone, Giacomo, et al.
Publicado: (2020)

A truncated Kv1.1 protein in the brain of the megencephaly mouse: expression and interaction
por: Persson, Ann-Sophie, et al.
Publicado: (2005)

Ligand with Two Modes of Interaction with the Dopamine D(2) Receptor–An Induced-Fit Mechanism of Insurmountable Antagonism
por: Ågren, Richard, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u4a5b57aju3ob9fet8c7em0n6p